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Editorial
Dear Readers,
Evidence-based medicine is a gold standard for creating clinical practice guidelines. On the other hand,
case-based reasoning may also be helpful in specific and rare clinical situations [1]. This issue of Advances in
Palliative Medicine includes a few case reports which we believe you will find helpful in the everyday practice.
Primary lung adenocarcinomas, particularly bronchoalveolar carcinoma, may produce large amounts of
bronchial excretion. Bronchorrhea may dramatically affect patient quality of life. There is no standard treat-
ment to control this symptom, however a common empirical approach is the use of steroids. Furthermore,
this subtype may be particularly sensitive to gefitinib and erlotinib — small molecule tyrosine kinase inhibi-
tors. Indeed a few reports showing dramatic improvement with these compounds have recently been
published [2, 3]. Zylicz Z reviewes the literature addressing bronchorrhea and presents a case successfully
treated with continuous subcutaneous infusion of a somatostatin analogue — octreotide. He also presents
another rare entity — nostalgia paraesthetica, which is characterized by pain and itching in a dorsal area,
usually at the level of Th2-6.
Janecki M and Janecka J describe advanced lung cancer patients referred to hospital, who developed
cognitive failure and delirium, and discuss possible interventions.
Finally, Celso B et al. compare self-perceived attitudes, confidence and concerns in relation to palliative
and end-of life care among residents in general surgery and family medicine. They conclude that in spite of
similarities and differences between both groups, the importance of palliation as a competency should be
formulated in a curriculum tailored to the specific requirements of a residency program.
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